TRANSFER OF VALUE REPORTING

Do you want to link to other websites and leave Amgen.com.au?

You are now leaving Amgen Australia’s website. Amgen Australia takes no responsibility for the information contained on the Amgen international server or site which you will be accessing. The information you are about to access may not comply with the Australian regulatory environment.

For Australian specific enquiries, please click here.

Do you want to link to other external websites and leave Amgen.com.au?

You are now leaving Amgen Australia’s website. Amgen Australia takes no responsibility for, and exercises no control over the organisation, views, or information contained on the server or site which you will be accessing. The information contained might not comply with the Australian regulatory environment.

Transfer of Value Reporting

Amgen is committed to fostering trust between industry, healthcare professionals and patients.

Amgen contributes to the quality use of medicines in Australia through the provision of education, sponsorship and support of healthcare professionals to attend educational and scientific meetings.

In line with community expectations, Amgen provides public disclosure of these interactions.

Transparency Disclosures

As a member of Medicines Australia, Amgen Australia Pty Ltd has undertaken to be open and transparent when we provide a reportable payment or transfer of value to a healthcare professional.

Reportable payments or transfers of value are:

  • Payments for the provision of services such as giving a lecture, chairing an educational meeting, providing advice as a member of an Advisory Board or as a Consultant.

  • Airfares, accommodation and/or conference registration fees to attend medical education as part of those services.

Amgen Australia has prepared these reports for publication in accordance with the Medicines Australia Code of Conduct, Edition 18 and Australia’s Privacy legislation. The reports identify healthcare professionals by name where their consent has been provided. Where consent has not been provided the information is reported in aggregate.

From 1 October 2016, reporting these payments became mandatory – details are reported because healthcare professionals should reasonably expect that all reportable payments or transfers of value will be disclosed for each healthcare professional, by name.

From 30 August 2019, this information will now be held in a database, administered by Medicines Australia.  This database is designed to be searchable as well as downloaded as a CSV file.

The reports for transfers of value made will be available for three years from the date of publication.

For further information about the details in the report, or to search the database, please visit www.DisclosureAustralia.com.au or www.medicinesaustralia.com.au.

The reports prior to 30 August are designed to be read on this website and are also provided as downloadable CSV files. To comply with our privacy obligations, the reports may be amended from time to time. Any use or disclosure of the data by a third party is the responsibility of that third party, who must comply with the Australian Privacy Act 1988.


1 May 2018 – 31 Oct 2018:

PDF format

CSV format

1 Nov 2017 – 30 Apr 2018:

PDF format

CSV format

1 May 2017 – 31 Oct 2017:

PDF format

CSV format

1 Nov 2016 – 30 Apr 2017:

PDF format

CSV format

Overview